Fox Run Management’s Amphastar Pharmaceuticals AMPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $487K | Buy |
+21,199
| New | +$487K | 0.08% | 477 |
|
|
2025
Q1 | – | Sell |
-18,526
| Closed | -$688K | – | 894 |
|
|
2024
Q4 | $688K | Buy |
+18,526
| New | +$688K | 0.12% | 317 |
|
|
2024
Q3 | – | Sell |
-6,487
| Closed | -$259K | – | 780 |
|
|
2024
Q2 | $259K | Sell |
6,487
-1,202
| -16% | -$48.1K | 0.05% | 590 |
|
|
2024
Q1 | $338K | Buy |
+7,689
| New | +$338K | 0.07% | 497 |
|
|
2017
Q1 | – | Sell |
-12,600
| Closed | -$232K | – | 558 |
|
|
2016
Q4 | $232K | Buy |
+12,600
| New | +$232K | 0.12% | 388 |
|